Search

Your search keyword '"Althoff, Keri N."' showing total 123 results

Search Constraints

Start Over You searched for: Author "Althoff, Keri N." Remove constraint Author: "Althoff, Keri N." Region united states Remove constraint Region: united states
123 results on '"Althoff, Keri N."'

Search Results

1. Racial/ethnic differences in the association between transgender-related U.S. state policies and self-rated health of transgender women.

2. Access to healthcare among transgender women living with and without HIV in the United States: associations with gender minority stress and resilience factors.

3. The forecasted prevalence of comorbidities and multimorbidity in people with HIV in the United States through the year 2030: A modeling study.

4. Evaluating Clinic-Based Interventions to Reduce Racial Differences in Mortality Among People With Human Immunodeficiency Virus in the United States.

5. PrEP initiation and discontinuation among transgender women in the United States: a longitudinal, mixed methods cohort study.

6. Hepatitis B care cascade among people with HIV/HBV coinfection in the North American AIDS Cohort Collaboration on Research and Design, 2012–2016.

7. Human Immunodeficiency Virus Status, Tenofovir Exposure, and the Risk of Poor Coronavirus Disease 19 Outcomes: Real-World Analysis From 6 United States Cohorts Before Vaccine Rollout.

8. A Growing Number of Men Who Have Sex With Men Aging With HIV (20212031): A Comparison of Two Microsimulation Models.

9. Characterizing Arrest and Incarceration in a Prospective Cohort of Transgender Women.

10. Five-Year Mortality for Adults Entering Human Immunodeficiency Virus Care Under Universal Early Treatment Compared With the General US Population.

11. Toward Ending the HIV Epidemic: Temporal Trends and Disparities in Early ART Initiation and Early Viral Suppression Among People Newly Entering HIV Care in the United States, 2012–2018.

12. Antibodies to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in All of Us Research Program Participants, 2 January to 18 March 2020.

13. Risk of Incident Diabetes Mellitus, Weight Gain, and Their Relationships With Integrase Inhibitor–Based Initial Antiretroviral Therapy Among Persons With Human Immunodeficiency Virus in the United States and Canada.

14. CD4 Count at Entry into Care and at Antiretroviral Therapy Prescription among Adults with Human Immunodeficiency Virus in the United States, 2005-2018.

15. Hospitalization Rates and Causes Among Persons With HIV in the United States and Canada, 2005-2015.

16. Association of Immunosuppression and Human Immunodeficiency Virus (HIV) Viremia With Anal Cancer Risk in Persons Living With HIV in the United States and Canada.

17. Characterizing the Human Immunodeficiency Virus Care Continuum Among Transgender Women and Cisgender Women and Men in Clinical Care: A Retrospective Time-series Analysis.

18. Real-world efficacy of direct acting antiviral therapies in patients with HIV/HCV.

19. Life-Expectancy Disparities Among Adults With HIV in the United States and Canada: The Impact of a Reduction in Drug- and Alcohol-Related Deaths Using the Lives Saved Simulation Model.

20. Viral suppression among persons in HIV care in the United States during 2009-2013: sampling bias in Medical Monitoring Project surveillance estimates.

21. One Size Fits (n)One: The Influence of Sex, Age, and Sexual Human Immunodeficiency Virus (HIV) Acquisition Risk on Racial/Ethnic Disparities in the HIV Care Continuum in the United States.

22. A systematic review of the geospatial barriers to antiretroviral initiation, adherence and viral suppression among people living with HIV.

23. Integrating Frailty Research into the Medical Specialties-Report from a U13 Conference.

24. Sex, Race, and HIV Risk Disparities in Discontinuity of HIV Care After Antiretroviral Therapy Initiation in the United States and Canada.

25. Geographic Variations in Retention in Care among HIV-Infected Adults in the United States.

26. Closing the Gap: Increases in Life Expectancy among Treated HIV-Positive Individuals in the United States and Canada.

27. Differential serum cytokine responses to inactivated and live attenuated seasonal influenza vaccines

28. U.S. Trends in Antiretroviral Therapy Use, HIV RNA Plasma Viral Loads, and CD4 T-Lymphocyte Cell Counts Among HIV-Infected Persons, 2000 to 2008.

29. Late Presentation for Human Immunodeficiency Virus Care in the United States and Canada.

30. Predictors of reported influenza vaccination in HIV-infected women in the United States, 2006–2007 and 2007–2008 seasons

31. CD4 count at presentation for HIV care in the United States and Canada: Are those over 50 years more likely to have a delayed presentation?

32. Opioid-related overdose mortality in the era of fentanyl: Monitoring a shifting epidemic by person, place, and time.

33. Prevention-effective adherence trajectories among transgender women indicated for PrEP in the United States: a prospective cohort study.

34. Projecting the age-distribution of men who have sex with men receiving HIV treatment in the United States.

35. Impact of subgroup-specific heterogeneities and dynamic changes in mortality rates on forecasted population size, deaths, and age distribution of persons receiving antiretroviral treatment in the United States: a computer simulation study.

36. Recent and projected incidence trends and risk of anal cancer among people with HIV in North America.

37. Enhanced Cohort Methods for HIV Research and Epidemiology (ENCORE): Protocol for a Nationwide Hybrid Cohort for Transgender Women in the United States.

38. The Contribution of Socioeconomic Factors to HIV RNA Suppression in Persons With HIV Engaged in Care in the NA-ACCORD.

39. Age-associated dementia among older people aging with HIV in the United States: a modeling study.

40. Moving Because of Unaffordable Housing and Disrupted Social Safety Net Access Among Children.

41. Food Insecurity Is High in a Multi-Site Cohort of Transgender Women Vulnerable to or Living with HIV in the Eastern and Southern United States: Baseline Findings from the LITE Cohort.

42. Hospital Readmissions Among Persons With Human Immunodeficiency Virus in the United States and Canada, 2005-2018: A Collaboration of Cohort Studies.

43. Association of Race and Ethnicity With Initial Prescription of Antiretroviral Therapy Among People With HIV in the US.

44. Longitudinal HIV care outcomes by gender identity in the United States.

45. SARS-CoV-2 Testing and Positivity Among Persons With and Without HIV in 6 US Cohorts.

46. CD4/CD8 Ratio and Cancer Risk Among Adults With HIV.

47. Analysis of Postvaccination Breakthrough COVID-19 Infections Among Adults With HIV in the United States.

48. Visualizing the Geography of HIV Observational Cohorts With Density-Adjusted Cartograms.

49. The shifting age distribution of people with HIV using antiretroviral therapy in the United States.

50. Clinical Effectiveness of Integrase Strand Transfer Inhibitor-Based Antiretroviral Regimens Among Adults With Human Immunodeficiency Virus: A Collaboration of Cohort Studies in the United States and Canada.

Catalog

Books, media, physical & digital resources